Complex systems biology approach to understanding coordination of JAK-STAT signaling

BioSystems

Volumn 90, Issue 3, 2007, Pages 830-842

  Soebiyanto, Radina P ^a   Sreenath, Sree N ^a   Qu, Cheng Kui ^b   Loparo, Kenneth A ^a   Bunting, Kevin D ^b  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Coordination; Hierarchical; JAK STAT; Mathematical modeling; Multilevel; Systems biology

Indexed keywords

JANUS KINASE; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

BIOCHEMISTRY; COHESION; DRUG; EXPERIMENTAL STUDY; HIERARCHICAL SYSTEM; INHIBITION; NUMERICAL MODEL; PATHOLOGY;

ARTICLE; BIOCHEMISTRY; BIOLOGY; COMPUTER MODEL; DRUG TARGETING; MATHEMATICAL MODEL; PATHOLOGY; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

EID: 35648941673     PISSN: 03032647     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biosystems.2007.05.005     Document Type: Article

References (27)

1. Aaronson D.A., and Horvath C.M. A road map for those who don't know JAK-STAT. Science 296 (2002) 1653-1655
2. Ali S., Nouhi Z., Chughtai N., and Ali S. SHP-2 regulates SOCS-1-mediated Janus Kinase-2 ubiquitination/degradation downstream of the prolactin receptor. J. Biol. Chem. 278 (2003) 52021-52031
3. Ashtagiri A.R., and Lauffenburger D.A. A computational study of feedback effects on signal dynamics in a Mitogen-Activated Protein Kinase (MAPK) pathway model. Biotech. Prog. 17 (2001) 227-239
4. γ signal transduction in vitro and in vivo. J. Biol. Chem. 276 25 (2001) 22086-22089
5. Buettner R., Mora L.B., and Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin. Cancer Res. 8 (2002) 945-954
6. Chen J., Yu W., Bunting K.D., and Qu C.-K. A negative role of SHP-2 tyrosine phosphatase in growth factor-dependent hematopoietic cell survival. Oncogene 23 20 (2004) 3659-3669
7. Chen Y., Wen R., Yang S., Schuman J., Zhang E., Yi T., Feng G.-S., and Wang D. Identification of SHP-2 as a STAT5A phosphatase. J. Biol. Chem. 278 (2003) 16520-16527
8. Chughtai N., Schimchowitsch S., Lebrun J.-J., and Ali S. Prolactin induces SHP-2 association with STAT5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells. J. Biol. Chem. 277 (2002) 31107-31114
9. Deckard A., and Sauro H.M. Preliminary studies on the in silico evolution of biochemical networks. ChemBiochem 5 10 (2004) 1423-1431
10. γ-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice. J. Exp. Med. 203 6 (2006) 1391-1397
11. Hartwell L.H., Hopfield J.J., Leibler S., and Murray A. From molecular to modular cell biology. Nature 402 (1999) 47-52
12. Lauffenburger D. Cell signaling pathways as control modules: complexity for simplicity. PNAS 57 10 (2000) 5031-5033
13. Lehmann U., Schmitz J., Weissenbach M., Sobota R.M., Hörtner M., Friederichs K., Behrmann I., Tsiaris W., Sasaki A., Schneider-Mergener J., Yoshimura A., Neel B.G., Heinrich P.C., and Schaper F. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130. J. Biol. Chem. 278 1 (2003) 661-671
14. Mesarovic M., Macko D., and Takahara Y. Theory of Hierarchical Multilevel System (1970), Academic Press, USA
15. Mesarovic M., Sreenath S., and Keene J. Search for organising principles: understanding in systems biology. IEE Syst. Biol. 1 1 (2004) 19-21
16. Meyer T., Marg A., Lemke P., Wiesner B., and Vinkemeier U. DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1. Genes Dev. 17 (2003) 1992-2005
17. Saez-Rodriguez J., Kremling A., and Gilles E. Dissecting the puzzle of life: modularization of signal transduction networks. Comput. Chem. Eng. 29 (2005) 619-629
18. Swameye I., Müller T., Timmer J., Sandra O., and Klingmüller U. Identification of nucleocytoplasmic cycling as a remote sensor in cellular signaling by data-based modelling. PNAS 100 (2003) 1028-1033
19. Valentino L., and Pierre J. JAK/STAT signal transduction: regulators and implication in hematological malignancies. Biochem. Pharmacol. 71 6 (2006) 713-721
20. Ward A.C., Touw I., and Yoshimura A. The JAK-STAT pathway in normal and perturbed hematopoiesis. Blood 95 1 (2000) 19-29
21. Wormald S., Zhang J.-G., Krebs D.L., Mielke L.A., Silver J., Alexander W.S., Speed T.P., Nicola N.A., and Hilton D.J. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling. J. Biol. Chem. 281 16 (2006) 11135-11143
22. Yamada S., Shiono S., Joo A., and Yoshimura A. Control mechanism of JAK/STAT signal transduction pathway. FEBS Lett. 534 (2003) 190-196
23. You M., Yu D., and Feng G.-S. SHP-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated JAK/STAT pathway. Mol. Cell. Biol. 19 (1999) 2416-2424
24. Yu C.-L., Jin Y.-J., and Burakoff S. Cytosolic tyrosine dephosphorylation of STAT5, Potential role of SHP2 in STAT5 regulation. J. Biol. Chem. 275 (2000) 599-604
25. Yu H., and Jove R. The STATs of cancer-new molecular targets come of age. Nat. Rev. Cancer 4 (2004) 97-105
26. Yu W.-M., Hawley T., and Qu C.-K. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling. Oncogene 22 38 (2003) 5995-6004
27. γ induced JAK-STAT signaling pathway. FEBS Lett. 579 (2005) 1101-1108